Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ovarian Cancer
New ovarian cancer research from J. Clarke and co-researchers described
November 11th, 2008
A new study, 'Assuring the quality of quality assurance: seeding abnormal slides into the negative Papanicolaou smears that will be rapid rescreened,' is now available. "Rapid rescreening (RR) of negative Papanicolaou smears (PS) is used in many countries as a quality-assurance measure. Seeding of abnormal slides has been suggested as a way to increase the sensitivity of this procedure," researchers in Australia report. "Since 2004, the authors have carried out RR with seeding before issuing reports. In this article, they describe their experience. Abnormal seeds were sourced from the previous day's high-grade cases, both squamous and glandular. Slides were evaluated...
Source: Cancer Weekly (2008-11-11)
|
